Mel Krajden BSc, MD (McG.), FRCPC

Dr. Mel Krajden, a Professor, is the Director of Hepatitis Services at BCCDC and Associate Director of the BCCDC Public Health Microbiology and Reference Laboratories. He oversees the research on the impact of hepatitis C virus on our society which has been recognized for the innovative advances of delivery of care to hepatitis patients outside large urban setting. His research focus is on the use of molecular markers to monitor anti-viral efficacy in vivo and of molecular techniques to track microbial infections for epidemiological purposes. He has particular expertise in quantitative nucleic acid testing of hepatitis B and C viruses and inter-assay evaluation. Recently he has undertaken research in human papillomaviruses including their detection in specific populations, their seroepidemiology and seroconversion after vaccination.